HDAC4 and hepatocellular carcinoma: Epigenetic alterations, such as DNA methylation or histone modification, in cancer often mediate the deregulation of tumour suppressors or oncogenes (Esteller, 2008), and HDAC4 expression potentiated by miR-22 downregulation may further aggravate the epigenetic changes in HCC.